Table 2.
Laboratory variables of participants by treatment allocation to ferric carboxymaltose or iron sucrose
| Ferric carboxymaltose n = 22 | Iron sucrose n = 20 | P | |
|---|---|---|---|
| Hemoglobin (g/L) | 111 ± 9 | 115 ± 10 | 0.14 |
| Iron (μmol/L) | 14.0 (11.0–16.0) | 10.5 (8.5–17.5) | 0.31 |
| Ferritin (μg/L) | 211 ± 133 | 187 ± 130 | 0.55 |
| Transferrin Saturation (%) | 29 ± 9 | 27 ± 12 | 0.64 |
| Transferrin (g/L) | 2.2 ± 0.4 | 2.2 ± 0.5 | 0.65 |
| Hepcidin (ng/mL) | 7.8 (2.7–12.6) | 3.4 (2.7–8.8) | 0.24 |
| iFGF23 (pg/mL) | 843 (313–1922) | 381 (245–1526) | 0.33 |
| cFGF23 (RU/mL) | 704 (475–1204) | 710 (448–1548) | 0.76 |
| PTH (pmol/L) | 40.0 (20.6–68.3) | 31.2 (16.6–42.2) | 0.22 |
| Ca (corrected) (mmol/L) | 2.30 ± 0.17 | 2.31 ± 0.15 | 0.90 |
| PO4 (mmol/L) | 1.53 ± 0.44 | 1.42 ± 0.44 | 0.41 |
| Albumin (g/L) | 35.5 ± 2.5 | 34.6 ± 2.8 | 0.27 |
| CRP (mg/L) | 4.5 (2.0–6.0) | 3.0 (2.0–5.0) | 0.33 |
RU/mL relative units per mL, CRP C-reactive protein